Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether metadoxine is effective for improve survival and reduced oxidative stress in patients with severe alcoholic hepatitis.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hospital General de Mexico
NCT06155760 · Severe Alcoholic Hepatitis
NCT04103840 · Severe Alcoholic Hepatitis, Chronic Liver Disease and Cirrhosis
NCT02808663 · Severe Alcoholic Hepatitis
NCT01820208 · Severe Alcoholic Hepatitis
Hospital General de Mexico
Mexico City, D.f.
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions